Meeting of the National Vaccine Advisory Committee, 69105-69106 [E9-30897]

Download as PDF Federal Register / Vol. 74, No. 249 / Wednesday, December 30, 2009 / Notices effective date. After this effective date, HHS will publish a notice in the Federal Register reporting the addition of this class to the SEC or the result of any provision by Congress regarding the decision by HHS to add the class to the SEC. FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Interim Director, Office of Compensation Analysis and Support, National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS C–46, Cincinnati, OH 45226, Telephone 513–533–6800 (this is not a toll-free number). Information requests can also be submitted by e-mail to OCAS@CDC.GOV. FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Interim Director, Office of Compensation Analysis and Support, National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS C–46, Cincinnati, OH 45226, Telephone 513–533–6800 (this is not a toll-free number). Information requests can also be submitted by e-mail to OCAS@CDC.GOV. John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. E9–30989 Filed 12–29–09; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–19–P Designation of a Class of Employees for Addition to the Special Exposure Cohort National Institute for Occupational Safety and Health (NIOSH), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: SUMMARY: HHS gives notice of a decision to designate a class of employees at the Oak Ridge Hospital, Oak Ridge, Tennessee, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On December 10, 2009, the Secretary of HHS designated the following class of employees as an addition to the SEC: mstockstill on DSKH9S0YB1PROD with NOTICES All employees of the Department of Energy, its predecessor agencies, and its contractors and subcontractors who worked in any location at the Oak Ridge Hospital in Oak Ridge, Tennessee, from May 15, 1950 through December 31, 1959, for a number of work days aggregating at least 250 work days or in combination with work days within the parameters established for one or more other classes of employees in the SEC. This designation will become effective on January 9, 2010, unless Congress provides otherwise prior to the effective date. After this effective date, HHS will publish a notice in the Federal Register reporting the addition of this class to the SEC or the result of any provision by Congress regarding the decision by HHS to add the class to the SEC. 19:01 Dec 29, 2009 Jkt 220001 BILLING CODE 4150–28–P Designation of a Class of Employees for Addition to the Special Exposure Cohort AGENCY: National Institute for Occupational Safety and Health (NIOSH), Department of Health and Human Services (HHS). ACTION: Notice. DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Nov<24>2008 John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. E9–30987 Filed 12–29–09; 8:45 am] SUMMARY: HHS gives notice of a decision to designate a class of employees at the Hanford site in Richland, Washington, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On December 10, 2009, the Secretary of HHS designated the following class of employees as an addition to the SEC: All employees of the Department of Energy, its predecessor agencies, and its contractors and subcontractors who worked at the Hanford site in Richland, Washington, from October 1, 1943 through June 30, 1972, for a number of work days aggregating at least 250 work days, occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees included in the Special Exposure Cohort. This designation will become effective on January 9, 2010, unless Congress provides otherwise prior to the effective date. After this effective date, HHS will publish a notice in the Federal Register reporting the addition of this class to the SEC or the result of any provision by Congress regarding the decision by HHS to add the class to the SEC. FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Interim Director, Office of Compensation Analysis and Support, National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 69105 C–46, Cincinnati, OH 45226, Telephone 513–533–6800 (this is not a toll-free number). Information requests can also be submitted by e-mail to OCAS@CDC.GOV. John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. E9–30985 Filed 12–29–09; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee AGENCY: Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice of meeting. SUMMARY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting. The meeting is open to the public. Preregistration is required for both public attendance and comment. Individuals who wish to attend the meeting and/or participate in the public comment session should either e-mail nvpo@hhs.gov or call 202–690–5566 to register. DATES: The meeting will be held on February 3, 2010, from 9 a.m. to 5:30 p.m., and February 4, 2010 from 8:30 a.m. to 5:30 p.m. ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, Department of Health and Human Services, Room 715–H, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201. Phone: (202) 690–5566; Fax: (202) 260– 1165; e-mail: nvpo@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. Section 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The National Vaccine Advisory Committee was established to provide advice and make recommendations to the Director of the National Vaccine Program, on matters related to the Program’s E:\FR\FM\30DEN1.SGM 30DEN1 69106 Federal Register / Vol. 74, No. 249 / Wednesday, December 30, 2009 / Notices responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. Topics to be discussed at the meeting include vaccine safety recommendations, the National Vaccine Plan, adult immunization recommendations, vaccine financing, 2009 H1N1 influenza outbreak, and other related issues. The meeting agenda will be posted on the website: www.hhs.gov/nvpo/nvac at least one week prior to the meeting. Public attendance at the meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the office at the address/phone listed above at least one week prior to the meeting. Members of the public will have the opportunity to provide comments at the meeting. Public comment will be limited to five minutes per speaker. Individuals who would like to submit written statements should email or fax their comments to the National Vaccine Program Office at least five business days prior to the meeting. Those wishing to register may do so by sending an email to nvpo@hhs.gov or by calling 202–690–5566 and providing name, e-mail address and organization. Dated: December 23, 2009. Bruce Gellin, Deputy Assistant Secretary for Health, Director, National Vaccine Program Office. [FR Doc. E9–30897 Filed 12–29–09; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2008–N–0546] Agency Information Collection Activities; Proposed Collection; Comment Request; Pet Food Early Warning Recall Rational Questionnaire as Part of the MedWatchPlus Portal and Rational Questionnaire Initiative AGENCY: Food and Drug Administration, HHS. mstockstill on DSKH9S0YB1PROD with NOTICES ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information and to allow for public comment in response to the notice. This VerDate Nov<24>2008 19:01 Dec 29, 2009 Jkt 220001 notice solicits comments on the data elements for the Rational Questionnaire which is being rolled out as part of the ongoing MedWatchPlus Portal and Rational Questionnaire initiative. DATES: Submit written or electronic comments on the collection of information by January 29, 2010. ADDRESSES: Submit electronic comments on the collection of information to https:// www.regulations.gov. Submit written comments on the collection of information to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Denver Presley Jr., Office of Information Management (HFA–710), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–796–3793. SUPPLEMENTARY INFORMATION: I. Background Under the PRA (44 U.S.C. 3501– 3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. ‘‘Collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal agencies to provide a notice in the Federal Register concerning each proposed collection of information before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document. With respect to the following collection of information, FDA invites comments on these topics: (1) Whether the proposed collection of information is necessary for the proper performance of FDA’s functions, including whether the information will have practical utility; (2) the accuracy of FDA’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 when appropriate, and other forms of information technology. II. Pet Food Early Warning Recall Rational Questionnaire as Part of the MedWatchPlus Portal and Rational Questionnaire Initiative (OMB Control No. 0910–0645)—Revision Section 1002(b) of the FDA Amendments Act of 2007 (FDAAA) (Public Law 110–85), directs the Secretary of Health and Human Services (the Secretary), to establish an early warning and surveillance system to identify adulteration of the pet food supply and outbreaks of illness associated with pet food. As part of the effort to fulfill that directive, the Secretary tasked FDA with developing the instrument that would allow consumers to report voluntarily adverse events associated with pet food. In a 60day Federal Register notice, which published on October 23, 2008 (73 FR 63153 at 63155), and a 30-day notice, which published on May 20, 2009 (74 FR 23721 at 23726), FDA announced the agency-wide information collection initiatives MedWatchPlus Portal and Rational Questionnaire. These initiatives are components of a larger electronic system being developed to collect, submit, and process adverse event reports and other safety information for all FDA-regulated products. The MedWatchPlus Portal, a Web-based portal, and the Rational Questionnaire, a user-friendly data collection tool, together make it easy for the public to report a safety problem. In this 30-day notice, FDA is requesting public comment on data elements associated with the roll out of the Pet Food Early Warning System component of the overall MedWatchPlusPortal and Rational Questionnaire initiative, whose framework and burden hours were approved under OMB Control Number 0910–0645. This notice refers to the instrument described in that information collection. FDA previously estimated the total burden hours associated with the Pet Food Early Warning System to be 324 hours (73 FR 63153 at 63155; 74 FR 23721 at 23726). The estimated burden hours associated with this information collection remain 324 total hours. III. Data Elements for Pet Food Early Warning System Rational Questionnaire In this 30-day notice, FDA is requesting public comment on data elements associated with the Pet Food Early Warning System component of the MedWatchPlus Portal and Rational Questionnaire initiatives. Following is a E:\FR\FM\30DEN1.SGM 30DEN1

Agencies

[Federal Register Volume 74, Number 249 (Wednesday, December 30, 2009)]
[Notices]
[Pages 69105-69106]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-30897]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of Public Health and Science.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a 
meeting. The meeting is open to the public. Pre-registration is 
required for both public attendance and comment. Individuals who wish 
to attend the meeting and/or participate in the public comment session 
should either e-mail nvpo@hhs.gov or call 202-690-5566 to register.

DATES: The meeting will be held on February 3, 2010, from 9 a.m. to 
5:30 p.m., and February 4, 2010 from 8:30 a.m. to 5:30 p.m.

ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey 
Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, 
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey 
Building, 200 Independence Avenue, SW., Washington, DC 20201. Phone: 
(202) 690-5566; Fax: (202) 260-1165; e-mail: nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. Section 300aa-1), the Secretary of Health 
and Human Services was mandated to establish the National Vaccine 
Program to achieve optimal prevention of human infectious diseases 
through immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The National Vaccine Advisory Committee was 
established to provide advice and make recommendations to the Director 
of the National Vaccine Program, on matters related to the Program's

[[Page 69106]]

responsibilities. The Assistant Secretary for Health serves as Director 
of the National Vaccine Program.
    Topics to be discussed at the meeting include vaccine safety 
recommendations, the National Vaccine Plan, adult immunization 
recommendations, vaccine financing, 2009 H1N1 influenza outbreak, and 
other related issues. The meeting agenda will be posted on the website: 
www.hhs.gov/nvpo/nvac at least one week prior to the meeting. Public 
attendance at the meeting is limited to space available. Individuals 
who plan to attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify the 
office at the address/phone listed above at least one week prior to the 
meeting. Members of the public will have the opportunity to provide 
comments at the meeting. Public comment will be limited to five minutes 
per speaker. Individuals who would like to submit written statements 
should e-mail or fax their comments to the National Vaccine Program 
Office at least five business days prior to the meeting. Those wishing 
to register may do so by sending an email to nvpo@hhs.gov or by calling 
202-690-5566 and providing name, e-mail address and organization.

    Dated: December 23, 2009.
Bruce Gellin,
Deputy Assistant Secretary for Health, Director, National Vaccine 
Program Office.
[FR Doc. E9-30897 Filed 12-29-09; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.